Oragenics Inc (OGEN)
1.06
-0.03
(-2.75%)
USD |
NYAM |
Apr 25, 16:00
1.12
+0.06
(+5.66%)
Pre-Market: 09:24
Oragenics Enterprise Value: 3.172M for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 3.172M |
| April 24, 2024 | 3.306M |
| April 23, 2024 | 3.306M |
| April 22, 2024 | 3.172M |
| April 19, 2024 | 3.485M |
| April 18, 2024 | 3.485M |
| April 17, 2024 | 3.261M |
| April 16, 2024 | 3.261M |
| April 15, 2024 | 3.888M |
| April 12, 2024 | 3.933M |
| April 11, 2024 | 3.933M |
| April 10, 2024 | 3.799M |
| April 09, 2024 | 4.112M |
| April 08, 2024 | 4.381M |
| April 05, 2024 | 3.620M |
| April 04, 2024 | 3.709M |
| April 03, 2024 | 4.336M |
| April 02, 2024 | 5.009M |
| April 01, 2024 | 4.829M |
| March 28, 2024 | 4.874M |
| March 27, 2024 | 4.695M |
| March 26, 2024 | 4.740M |
| March 25, 2024 | 4.784M |
| March 22, 2024 | 5.009M |
| March 21, 2024 | 5.009M |
| Date | Value |
|---|---|
| March 20, 2024 | 4.650M |
| March 19, 2024 | 4.784M |
| March 18, 2024 | 4.740M |
| March 15, 2024 | 4.695M |
| March 14, 2024 | 4.874M |
| March 13, 2024 | 4.874M |
| March 12, 2024 | 4.829M |
| March 11, 2024 | 4.829M |
| March 08, 2024 | 4.964M |
| March 07, 2024 | 5.054M |
| March 06, 2024 | 4.964M |
| March 05, 2024 | 4.874M |
| March 04, 2024 | 4.964M |
| March 01, 2024 | 4.829M |
| February 29, 2024 | 2.827M |
| February 28, 2024 | 2.796M |
| February 27, 2024 | 5.970M |
| February 26, 2024 | 8.157M |
| February 23, 2024 | 8.527M |
| February 22, 2024 | 8.557M |
| February 21, 2024 | 8.758M |
| February 20, 2024 | 9.790M |
| February 16, 2024 | 9.574M |
| February 15, 2024 | 9.512M |
| February 14, 2024 | 9.112M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-4.262M
Minimum
Mar 27 2023
142.74M
Maximum
Feb 12 2021
22.43M
Average
14.78M
Median
Oct 13 2022
Enterprise Value Benchmarks
| Palatin Technologies Inc | 18.27M |
| Inogen Inc | 22.69M |
| Cyclacel Pharmaceuticals Inc | -1.269M |
| Actinium Pharmaceuticals Inc | 116.16M |
| MAIA Biotechnology Inc | 48.01M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -12.75M |
| Total Expenses (Quarterly) | 12.80M |
| EPS Diluted (Quarterly) | -5.48 |
| Earnings Yield | -872.6% |
| Normalized Earnings Yield | -8480.71 |